General MedicationsORALStandard

LEVOTHYROXINE SODIUM

Standard Dose

0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Prescription

Summary

Approval overview LEVOTHYROXINE SODIUM is listed in Drugs@FDA under application 215259 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient LEVOTHYROXINE SODIUM Form and strength TABLET;ORAL - 0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium Sponsor ASCENT PHARMS INC Submission history Latest submission status date: 2023-01-18 00:00:00.

Structured Monograph

Clinical summary

Approval overview LEVOTHYROXINE SODIUM is listed in Drugs@FDA under application 215259 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient LEVOTHYROXINE SODIUM Form and strength TABLET;ORAL - 0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium Sponsor ASCENT PHARMS INC Submission history Latest submission status date: 2023-01-18 00:00:00. Submission type: ORIG.

Monitoring

• Marketing status: Prescription
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.